An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), has developed the drug, in collaboration with Dr Reddy’s Laboratories, Hyderabad.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by day-3 in comparison to SOC, indicating an early relief from oxygen therapy/dependence. The drug comes in the form of a powder in a sachet & is supposed to be dissolved in water.
Important takeaways for all competitive exams:
India's campaign at the Asian Games 2026 kick-off in Aichi-Nagoya in Japan, on the first…
Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…
Tamil Nadu has the highest number of registered GI-tagged textile and handloom items compared to…
Flight Lieutenant Alfred Tyrone Cooke, a highly decorated veteran of Indian Air Force and a…
The Karnataka state government has made the Tulu as the second additional administrative language of…
Tamil Nadu Chief Minister C Joseph Vijay will inaugurate the state's scheme of providing gold…